Pfizer board member Dr. Scott Gottlieb warned that the United States lacks a federal infrastructure capable of dealing with public health emergencies such as monkeypox.
Gottlieb claimed the United States did not test enough people for the virus, which is overwhelmingly spreading via homosexual men, in the early part of the outbreak while the U.S. Centers for Disease Control and Prevention (CDC) should have utilized commercial labs sooner. It wasn’t until June that the CDC expanded to using those labs, he noted.
More Details
“Its cultural instinct is to take a deliberative approach, debating each decision,” Gottlieb said of the CDC’s response. “With COVID, the virus gained ground quickly. With monkeypox, which spreads more slowly, typically through very close contact, the shortcomings of CDC’s cultural approach haven’t been as acute yet. But the shortfalls are the same.”While the CDC should change course and re-focus its core mission on containing outbreaks, Gottlieb said he believes it’s not likely to do so.
“After COVID, there’s a view among some that public health agencies used flawed analysis and miscalculated their advice,” Gottlieb wrote. “Securing a political consensus that the CDC needs to be further empowered to complete its mission —for example, invested with the authority to compel reporting from states—is politically unobtainable.”